KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Debt Ratio: 2010-2025

Historic Debt Ratio for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to 0.45.

  • Emergent BioSolutions' Debt Ratio rose 1.35% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year increase of 1.35%. This contributed to the annual value of 0.48 for FY2024, which is 95.01% up from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Debt Ratio is 0.45, which was down 3.69% from 0.47 recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Debt Ratio ranged from a high of 0.48 in Q4 2024 and a low of 0.14 during Q4 2022.
  • In the last 3 years, Emergent BioSolutions' Debt Ratio had a median value of 0.30 in 2024 and averaged 0.34.
  • Its Debt Ratio has fluctuated over the past 5 years, first plummeted by 48.24% in 2022, then spiked by 95.01% in 2024.
  • Emergent BioSolutions' Debt Ratio (Quarterly) stood at 0.27 in 2021, then crashed by 48.24% to 0.14 in 2022, then skyrocketed by 72.89% to 0.24 in 2023, then soared by 95.01% to 0.48 in 2024, then rose by 1.35% to 0.45 in 2025.
  • Its Debt Ratio was 0.45 in Q3 2025, compared to 0.47 in Q2 2025 and 0.47 in Q1 2025.